Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib, Bendamustine, and Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT02056756Phase 2Completed
- Start
- Apr 2014
- Primary completion
- Sep 2015
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 2
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM). Started Apr 2014; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02056756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02056756.